Shigella Vaccines: The Continuing Unmet Challenge

Area of Science:

• * Infectious Diseases
• * Vaccinology
• * Microbiology

Background:

• * Shigellosis, a severe gastrointestinal illness, affects millions globally, with high mortality in low-income regions and significant impact on young children.
• * Antibiotic resistance exacerbates the public health concern of shigellosis, necessitating novel prevention strategies.
• * The disease causes malnutrition and impaired growth, particularly in children aged 2-5 years.

Purpose of the Study:

• * To review the current status of Shigella vaccine candidates.
• * To explore potential Shigella immunogens and innovative vaccine development approaches.
• * To identify challenges in advancing effective Shigella prevention and control.

Main Methods:

• * Comprehensive literature review of Shigella pathology and vaccine research.
• * Analysis of various vaccine strategies: killed whole-cells, live attenuated, LPS-based, and subunit vaccines.
• * Evaluation of immunogens (LPS, T3SS proteins, outer membrane proteins) and animal models in vaccine development.

Main Results:

• * Multiple Shigella vaccine candidates are under investigation, each with distinct advantages and limitations.
• * Research explores diverse immunogens and utilizes various animal models to assess vaccine efficacy.
• * Innovative approaches are being developed to overcome existing hurdles in Shigella vaccine research.

Conclusions:

• * Developing effective Shigella vaccines is crucial for global public health, particularly in vulnerable populations.
• * Addressing antibiotic resistance and improving vaccine efficacy remain key challenges.
• * Continued research into novel immunogens and vaccine platforms is essential for controlling shigellosis.